Variant report
Variant | esv3474472 |
---|---|
Chromosome Location | chr6:31191573-31196171 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL3 | chr6:31193764-31194173 | GM12878 | blood: | n/a | n/a |
2 | BCL3 | chr6:31193853-31194184 | GM12878 | blood: | n/a | n/a |
3 | E2F6 | chr6:31192506-31193237 | H1-hESC | embryonic stem cell: | n/a | chr6:31192992-31193004 |
4 | E2F6 | chr6:31192791-31193210 | H1-hESC | embryonic stem cell: | n/a | chr6:31192992-31193004 |
5 | FOXA1 | chr6:31193504-31193822 | T-47D | breast: | n/a | n/a |
6 | FOXA1 | chr6:31193515-31193926 | T-47D | breast: | n/a | n/a |
7 | FOXA2 | chr6:31193586-31193779 | HepG2 | liver: | n/a | n/a |
8 | GATA3 | chr6:31193518-31194205 | T-47D | breast: | n/a | n/a |
9 | GATA3 | chr6:31193679-31194224 | MCF-7 | breast: | n/a | n/a |
10 | GATA3 | chr6:31193513-31194205 | T-47D | breast: | n/a | n/a |
11 | MYC | chr6:31192180-31192210 | HUVEC | blood vessel: | n/a | n/a |
12 | NFATC1 | chr6:31193737-31194175 | GM12878 | blood: | n/a | n/a |
13 | PBX3 | chr6:31193861-31194105 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr6:31192262-31192397 | K562 | blood: | n/a | n/a |
15 | POLR2A | chr6:31192123-31192392 | ProgFib | skin: | n/a | n/a |
16 | POLR2A | chr6:31192263-31192296 | MCF-7 | breast: | n/a | n/a |
17 | POLR2A | chr6:31192054-31192468 | GM12892 | blood: | n/a | n/a |
18 | POLR2A | chr6:31192106-31192351 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr6:31192273-31192547 | HepG2 | liver: | n/a | n/a |
20 | POLR2A | chr6:31192059-31192456 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr6:31192128-31192317 | HepG2 | liver: | n/a | n/a |
22 | POLR2A | chr6:31192110-31192315 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | POLR2A | chr6:31192077-31192456 | GM12892 | blood: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:31190775..31192642-chr6:31491584..31493924,2 | K562 | blood: | |
2 | chr6:31190078..31192585-chr6:31195743..31198639,3 | K562 | blood: | |
3 | chr6:31169209..31171865-chr6:31193364..31195422,2 | K562 | blood: | |
4 | chr6:31190770..31192305-chr6:31497957..31500169,2 | K562 | blood: | |
5 | chr6:31195002..31197168-chr6:31331435..31333390,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255899 | TF binding region |
ENSG00000271821 | chromatin interactions |
ENSG00000255726 | chromatin interactions |
ENSG00000198563 | chromatin interactions |
ENSG00000206344 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117321340 | chr6:31191633-31191634 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs1639110 | chr6:31191636-31191637 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs567836009 | chr6:31191642-31191643 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs9281267 | chr6:31191657-31191658 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs150398191 | chr6:31191671-31191672 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs193105366 | chr6:31191691-31191692 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs3130518 | chr6:31191709-31191710 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs149162659 | chr6:31191744-31191745 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs146782361 | chr6:31191785-31191786 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs546674956 | chr6:31191852-31191853 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs3130949 | chr6:31191867-31191868 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs535265851 | chr6:31191905-31191906 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs557133709 | chr6:31191919-31191920 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs575427955 | chr6:31191929-31191930 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs117322540 | chr6:31191932-31191933 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs9501525 | chr6:31191978-31191979 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs531187013 | chr6:31192012-31192013 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs572861286 | chr6:31192033-31192034 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs540238715 | chr6:31192053-31192054 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs562016224 | chr6:31192057-31192058 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs200854305 | chr6:31192058-31192059 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs150285531 | chr6:31192063-31192064 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs552905490 | chr6:31192064-31192065 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs374331827 | chr6:31192066-31192067 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs115878234 | chr6:31192110-31192111 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs563124287 | chr6:31192117-31192118 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs1793895 | chr6:31192192-31192193 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs550030867 | chr6:31192201-31192202 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs9263990 | chr6:31192215-31192216 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs145568104 | chr6:31192228-31192229 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs138522297 | chr6:31192229-31192230 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs535967223 | chr6:31192236-31192237 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs528044815 | chr6:31192243-31192244 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs200200901 | chr6:31192310-31192311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79925243 | chr6:31192336-31192337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202079233 | chr6:31192362-31192363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143342069 | chr6:31192365-31192366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568027275 | chr6:31192371-31192372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114573401 | chr6:31192383-31192384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533954276 | chr6:31192414-31192415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569074828 | chr6:31192455-31192456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147106027 | chr6:31192462-31192463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373006059 | chr6:31192465-31192466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185499096 | chr6:31192493-31192494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9263991 | chr6:31192509-31192510 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs533901880 | chr6:31192510-31192511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190070360 | chr6:31192520-31192521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200216133 | chr6:31192566-31192567 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9263992 | chr6:31192587-31192588 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs539827890 | chr6:31192644-31192645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:31179200-31195000 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr6:31183200-31192600 | Weak transcription | Spleen | Spleen |
3 | chr6:31189000-31196400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:31190000-31192800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
5 | chr6:31190400-31191600 | Enhancers | Fetal Stomach | stomach |
6 | chr6:31190800-31197600 | Weak transcription | Right Atrium | heart |
7 | chr6:31191000-31193000 | Weak transcription | Colonic Mucosa | Colon |
8 | chr6:31192400-31193200 | Enhancers | Pancreas | Pancrea |
9 | chr6:31192600-31192800 | Enhancers | Spleen | Spleen |
10 | chr6:31192800-31193000 | Enhancers | Placenta | Placenta |
11 | chr6:31192800-31193200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
12 | chr6:31192800-31193200 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr6:31192800-31193200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr6:31192800-31193200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr6:31193000-31193200 | Enhancers | Colonic Mucosa | Colon |
16 | chr6:31193000-31193400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
17 | chr6:31193200-31196400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
18 | chr6:31193200-31196400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
19 | chr6:31193200-31196400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr6:31193200-31196600 | Weak transcription | Colonic Mucosa | Colon |
21 | chr6:31193200-31201600 | Weak transcription | Primary hematopoietic stem cells | blood |
22 | chr6:31193400-31193800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
23 | chr6:31193800-31194000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
24 | chr6:31194000-31196400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
25 | chr6:31194800-31195000 | Weak transcription | Left Ventricle | heart |
26 | chr6:31195000-31195200 | Enhancers | H9 Cell Line | embryonic stem cell |
27 | chr6:31195000-31195200 | Enhancers | Left Ventricle | heart |
28 | chr6:31195000-31195200 | Enhancers | Right Ventricle | heart |
29 | chr6:31195200-31195400 | Enhancers | Fetal Lung | lung |
30 | chr6:31195200-31195400 | Bivalent Enhancer | K562 | blood |
31 | chr6:31195200-31196200 | Weak transcription | Left Ventricle | heart |
32 | chr6:31195400-31196400 | Weak transcription | Right Ventricle | heart |